Ratio Review: Analyzing Outlook Therapeutics Inc (OTLK)’s Price-to-Cash and Price-to-Free Cash Flow

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $1.47 in the prior trading day, Outlook Therapeutics Inc (NASDAQ: OTLK) closed at $1.52, up 3.40%. In other words, the price has increased by $3.40 from its previous closing price. On the day, 0.97 million shares were traded. OTLK stock price reached its highest trading level at $1.5799 during the session, while it also had its lowest trading level at $1.47.

Ratios:

Our goal is to gain a better understanding of OTLK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.07.

On March 27, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $50.

Chardan Capital Markets Upgraded its Neutral to Buy on February 15, 2024, while the target price for the stock was maintained at $3.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 26 ’24 when KENYON LAWRENCE A bought 5,000 shares for $5.69 per share. The transaction valued at 28,446 led to the insider holds 5,946 shares of the business.

Haddadin Yezan Munther bought 1,882 shares of OTLK for $22,242 on Mar 28 ’24. The Director now owns 5,049 shares after completing the transaction at $11.82 per share. On Mar 07 ’24, another insider, Evanson Jeff, who serves as the CHIEF COMMERCIAL OFFICER of the company, bought 62,484 shares for $0.42 each. As a result, the insider paid 26,243 and bolstered with 808,459 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 35956512 and an Enterprise Value of 36656376.

Stock Price History:

Over the past 52 weeks, OTLK has reached a high of $12.85, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -69.46%, while the 200-Day Moving Average is calculated to be -78.54%.

Shares Statistics:

The stock has traded on average 1.54M shares per day over the past 3-months and 8398270 shares per day over the last 10 days, according to various share statistics. A total of 23.41M shares are outstanding, with a floating share count of 15.23M. Insiders hold about 35.60% of the company’s shares, while institutions hold 35.70% stake in the company. Shares short for OTLK as of 1731628800 were 3398949 with a Short Ratio of 2.21, compared to 1728950400 on 2989293. Therefore, it implies a Short% of Shares Outstanding of 3398949 and a Short% of Float of 21.149999.

Most Popular